Jefferies Downgrades Replimune Group (REPL) to Hold

April 13, 2026 3:41 AM

Jefferies analyst Roger Song downgraded Replimune Group (NASDAQ: REPL) from Buy to Hold with a price target of $2.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found